Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
new york blog main
3
×
alnylam pharmaceuticals
amgen
cancer
national top stories
new york top stories
novartis
the medicines company
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alirocumab
alopecia areata
amarin
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
biotech ipos
bolt biotherapeutics
boston
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cell therapy
cidara therapeutics
cigna
codiak biosciences
concert pharmaceuticals
What
brings
3
×
new
drug
medicines
acquire
advantages
agreed
bar
based
begin
billion
bio
biosciences
bio’s
bubbles
cash
cells
cholesterol
class
clinical
codiak
company
compound
deal
exosome
exosomes
expect
fda
formed
fund
gamble
ipo
market
medco
medco’s
million
mover
novartis
patients
payers
Language
unset
3
×
Current search:
brings
×
unset
×
" new york blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone